===CVRx, Inc. (CVRX) reports Positive news on outpatient payment for Barostim

 

• Co announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to keep the Barostim implant procedure as part of the New Technology Ambulatory Payment Classification (APC) 1580, with an associated payment of approximately $45,000 for procedures performed in the outpatient setting. CMS is also soliciting comments about the need for a Level 6 Neurostimulator APC. We expect CMS will publish the 2026 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule in November, which is expected to take effect on January 1, 2026.
• This proposal follows two other positive developments in the last nine months relating to reimbursement rates. As of Oct. 1, 2024, Barostim was assigned to a higher paying MS-DRG for inpatient procedures. In that same month it was announced that Barostim will transition from Category III to Category I CPT codes for physician payments as of Jan. 1, 2026. These reimbursement updates underscore the clinical value of Barostim and reinforce its role in the heart failure care continuum.

IPOs this week : June 28 - July 2, 2021 (wk 26)

IPOs expected to price

• DingDong (NYSE:DDL), 

• SentinelOne (NYSE:S), 

• Intapp (NASDAQ:INTA), 

• Xometry (NASDAQ:XMTR), 

• Integral Ad Science Holding (NASDAQ:IAS), 

• CVRx (NASDAQ:CVRX), 

• D-Market Elektronik Hizmetler ve Ticaret (NASDAQ:HEPS), 

• Krispy Kreme (DNUT) and 

• Torrid Holdings (NYSE:CURV). 

Across the Pacific, the XPeng (NYSE:XPEV) listing in Hong Kong will be priced next week at the lower end of the international offer price or at HK$180, whichever is lower.

Krispy Kreme IPO preview: Krispy Kreme (DNUT) is making its second run as a publicly-traded company. Krispy Kreme will raise about $600M at the midpoint of its expected pricing range and have a valuation of around $3.8B."Krispy Kreme's story has changed over the years, and expanded beyond the company's original product lines to include a broader reaching product assortment (doughnuts, coffee, packaged goods, and its Insomnia Cookies brand subsidiary) and global footprint (domestic/international company-operated & franchised units, distribution, and retail business)," updates MKM Partners analyst Brett Levy on the IPO.

Torrid IPO preview: Torrid Holdings (CURV) plans to offer 8M shares in a price range of $18 to $21. Torrid is the largest direct-to-consumer brand of women’s plus-size apparel and intimates in North America. Torrid has over 600 stores in operation across 36 U.S. states. The IPO is the first for the mall sector in over two years.